Literature DB >> 12595441

Phenotypic switching in Mycoplasma gallisepticum hemadsorption is governed by a high-frequency, reversible point mutation.

Florian Winner1, Ivana Markovà, Peter Much, Albin Lugmair, Karin Siebert-Gulle, Gunther Vogl, Renate Rosengarten, Christine Citti.   

Abstract

Mycoplasma gallisepticum is a flask-shaped organism that commonly induces chronic respiratory disease in chickens and infectious sinusitis in turkeys. Phenotypic switching in M. gallisepticum hemadsorption (HA) was found to correlate with phase variation of the GapA cytadhesin concurrently with that of the CrmA protein, which exhibits cytadhesin-related features and is encoded by a gene located downstream of the gapA gene as part of the same transcription unit. In clones derived from strain R(low), detailed genetic analyses further revealed that on-off switching in GapA expression is governed by a reversible base substitution occurring at the beginning of the gapA structural gene. In HA(-) variants, this event generates a stop codon that results in the premature termination of GapA translation and consequently affects the expression of CrmA. Sequences flanking the mutation spot do not feature any repeated motifs that could account for error-prone mutation via DNA slippage and the exact mechanism underlying this high-frequency mutational event remains to be elucidated. An HA(-) mutant deficient in producing CrmA, mHAD3, was obtained by disrupting the crmA gene by using transposition mutagenesis. Despite a fully functional gapA gene, the amount of GapA detected in this mutant was considerably lower than in HA(+) clonal variants, suggesting that, in absence of CrmA, GapA might be subjected to a higher turnover.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595441      PMCID: PMC148866          DOI: 10.1128/IAI.71.3.1265-1273.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Structure, function, and assembly of the terminal organelle of Mycoplasma pneumoniae.

Authors:  D C Krause; M F Balish
Journal:  FEMS Microbiol Lett       Date:  2001-04-20       Impact factor: 2.742

2.  Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA).

Authors:  M S Goh; T S Gorton; M H Forsyth; K E Troy; S J Geary
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

3.  Mycoplasma hyorhinis vlp gene transcription: critical role in phase variation and expression of surface lipoproteins.

Authors:  C Citti; K S Wise
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

4.  Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions.

Authors:  M D Glew; N Baseggio; P F Markham; G F Browning; I D Walker
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Expression of two members of the pMGA gene family of Mycoplasma gallisepticum oscillates and is influenced by pMGA-specific antibodies.

Authors:  P F Markham; M D Glew; G F Browning; K G Whithear; I D Walker
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Transformation of Mycoplasma gallisepticum with Tn916, Tn4001, and integrative plasmid vectors.

Authors:  J Cao; P A Kapke; F C Minion
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

7.  Comparison of in vivo and in vitro methods for pathogenicity evaluation for Mycoplasma gallisepticum in respiratory infection.

Authors:  S Levisohn; M J Dykstra; M Y Lin; S H Kleven
Journal:  Avian Pathol       Date:  1986       Impact factor: 3.378

8.  Mycoplasma hyorhinis GDL surface protein antigen p120 defined by monoclonal antibody.

Authors:  K S Wise; R K Watson
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Interplay between mycoplasmas and host target cells.

Authors:  J B Baseman; M Lange; N L Criscimagna; J A Giron; C A Thomas
Journal:  Microb Pathog       Date:  1995-08       Impact factor: 3.738

10.  Expression studies on four members of the pMGA multigene family in Mycoplasma gallisepticum S6.

Authors:  M D Glew; P F Markham; G F Browning; I D Walker
Journal:  Microbiology       Date:  1995-11       Impact factor: 2.777

View more
  13 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

3.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  The oppD Gene and Putative Peptidase Genes May Be Required for Virulence in Mycoplasma gallisepticum.

Authors:  Chi-Wen Tseng; Chien-Ju Chiu; Anna Kanci; Christine Citti; Renate Rosengarten; Glenn F Browning; Philip F Markham
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

5.  Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal-organelle development.

Authors:  Raul Burgos; Oscar Q Pich; Mario Ferrer-Navarro; Joel B Baseman; Enrique Querol; Jaume Piñol
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

6.  Mycoplasma gallisepticum invades chicken erythrocytes during infection.

Authors:  Gunther Vogl; Astrid Plaickner; Susan Szathmary; László Stipkovits; Renate Rosengarten; Michael P Szostak
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

7.  Role of the GapA and CrmA cytadhesins of Mycoplasma gallisepticum in promoting virulence and host colonization.

Authors:  Ivana Indiková; Peter Much; László Stipkovits; Karin Siebert-Gulle; Michael P Szostak; Renate Rosengarten; Christine Citti
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

8.  First steps towards the genetic manipulation of Mycoplasma agalactiae and Mycoplasma bovis using the transposon Tn4001mod.

Authors:  Rohini Chopra-Dewasthaly; Martina Zimmermann; Renate Rosengarten; Christine Citti
Journal:  Int J Med Microbiol       Date:  2005-01       Impact factor: 3.473

9.  First identification of proteins involved in motility of Mycoplasma gallisepticum.

Authors:  Ivana Indikova; Martin Vronka; Michael P Szostak
Journal:  Vet Res       Date:  2014-10-17       Impact factor: 3.683

10.  Development of a site-directed integration plasmid for heterologous gene expression in Mycoplasma gallisepticum.

Authors:  Isolde Nieszner; Martin Vronka; Ivana Indikova; Michael P Szostak
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.